A study on pacemaker pocket infection
Article Sidebar
Main Article Content
Abstract
Objective: Cardiac implantable electronic device (CIED) infections now constitute ∼ 10% of all endocarditis cases. The incidence of CIED infection is usually < 2%. Our objective was to study pacemaker pocket infection rate and different risk factors in our institution.
Methods: This observational study was conducted over a period of five years from January 2011 to December 2016 and it included 1096 patients. Common risk factors like patients with diabetes, repeat procedure, chronic renal failure, chronic obstructive airway disease, immunosuppressive agents were studied in our patients.
Results: Our study consisted of 1096 patients. Pacemaker pocket infection occurred in sixteen patients (1.5%). Chronic renal failure patients were one hundred thirty in our study (11.86%). There were three hundred fifty six diabetic patients (32.48%). Repeat procedure was done in ninety five patients (8.6%).
Results: Our study consisted of 1096 patients. Pacemaker pocket infection occurred in sixteen patients (1.5%). Chronic renal failure patients were one hundred thirty in our study (11.86%). There were three hundred fifty six diabetic patients (32.48%). Repeat procedure was done in ninety five patients (8.6%)
Eighty six patients were suffering from chronic obstructive airway (7.8%). Patients on immunosuppressive therapy were fourteen in our study (1.2%).
Conclusion: Pacemaker pocket infections is a dreaded complication after pacemaker implantation. During implantation, there is a risk of device contamination with the patient’s own skin flora and it can be prevented by ideal surgical asepsis technique, pre and perioperative use of antibiotics.
Article Details
Copyright (c) 2020 Datta G.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The Journal of Cardiology and Cardiovascular Medicine is committed in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. In order to use the Open Access paradigm to the maximum extent in true terms as free of charge online access along with usage right, we grant usage rights through the use of specific Creative Commons license.
License: Copyright © 2017 - 2025 | 
Open Access by Journal of Cardiology and Cardiovascular Medicine is licensed under a Creative Commons Attribution 4.0 International License. Based on a work at Heighten Science Publications Inc.
With this license, the authors are allowed that after publishing with the journal, they can share their research by posting a free draft copy of their article to any repository or website.
Compliance 'CC BY' license helps in:
| Permission to read and download | ✓ |
| Permission to display in a repository | ✓ |
| Permission to translate | ✓ |
| Commercial uses of manuscript | ✓ |
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
Nery PB, Fernandes R, Nair GM, Sumner GL, Ribas CS, et al. Device-related infection among patients with pacemakers and implantable defibrillators: incidence, risk factors, and consequences. J Cardiovasc Electrophysiol. 2010: 21, 786- 90. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/20102431
Cantillon DJ, Exner DV, Badie N, Davis K, Gu NY, et al. Complications and Health Care Costs Associated With Transvenous Cardiac Pacemakers in a Nationwide Assessment. JACC: Clinical Electrophysiology. 2017; 3: 1296-1305. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29759627
Poole JE, Gleva MJ, Mela T, Chung MK, Uslan DZ, et al. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry. Circulation. 2010; 122:1553-1561. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/20921437
Margey R, McCann H, Blake G, Keelan E, Galvin J, et al .Contemporary management of and outcomes from cardiac device related infections. Europace. 2010; 12: 64 -70. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19910314
Sohail MR, Henrikson CA, Braid Forbes MJ, Forbes KF, Lerner DJ. Mortality and cost associated with cardiovascular implantable electronic device infections. Arch Intern Med. 2011; 171: 182-186. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21911623
Greenspon AJ, Patel JD, Lau E, Ochoa JA, Frisch DR, et al. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. J Am Coll Cardiol. 2011; 58: 1001-1006. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21867833
Lee I, Agarwal RK, Lee BY, Fishman NO, Umscheid CA. Systematic review and cost analysis comparing use of chlorhexidine with use of iodine for preoperative skin antisepsis to prevent surgical site infection. Infect Control Hosp Epidemiol. 2010; 31: 1219- 1229. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/20969449
Bertaglia E, Zerbo F, Zardo S, Barzan D, Zoppo F, et al. Antibiotic prophylaxis with a single dose of cefazolin during pacemaker implantation: incidence of long-term infective complications. Pacing Clin Electrophysiol. 2006; 29: 29-33. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/16441714
Lakkireddy D, Valasareddi S, Ryschon K, Basarkodu K, Rovang K, et al. The impact of povidone-iodine pocket irrigation use on pacemaker and defibrillator infections. Pacing Clin Electrophysiol. 2005; 28: 789- 794. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/16105006
Athan E, Chu VH, Tattevin P, Selton-Suty C, Jones P, et al. Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices. JAMA. 2012; 307: 1727- 1735. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22535857
Darouiche R, Mosier M, Voigt J. Antibiotics and antiseptics to prevent infection in cardiac rhythm management device implantation surgery. Pacing and Clinical Electrophysiology. 2012; 35: 1348- 1360. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22946683
Konstantinos A, Polyzos Athanasios A, Konstantelias Matthew E. Falagas. Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis. Europace. 2015; 17: 767–767. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25926473